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Abstract
Background: In the setting of myocardial infarction (MI) or acute coronary syndrome (ACS), current guidelines
recommend early and aggressive lipid lowering therapy with statins, irrespective of the baseline lipoprotein levels.
Takotsubo cardiomyopathy (TCM) patients have a clinical presentation similar to myocardial infarction and thus
receive early and aggressive statin therapy during their initial hospitalization. However, the pathology of TCM is not
atherosclerotic coronary artery disease and hence we assumed the lipid profiles in TCM would be healthier than
coronary artery disease patients.
Methods: In this retrospective study, we assessed fasting serum lipoprotein levels of ten TCM patients and
compared them with forty, age and sex-matched myocardial infarction (MI) patients.
Results: Comparing serum lipoprotein levels of TCM with MI group, there was no significant difference in mean
total cholesterol between the two groups (174.5 mg/dL vs. 197.6 mg/dL, p = 0.12). However, in the TCM group,
mean HDL-C was significantly higher (66.87 mg/dL vs. 36.5 mg/dL, p = 0.008), the mean LDL-C was significantly
lower (89.7 mg/dL vs. 128.9 mg/dL, p = 0.0002), and mean triglycerides was also significantly lower (65.2 mg/dL vs.
166.8 mg/dL, p < 0.0001).
Conclusions: In this study, TCM patients in comparison to MI patients had significantly higher levels of HDL-C,
lower levels of LDL-C levels and triglycerides. The lipid profiles in TCM were consistent with the underlying
pathology of non-atherosclerotic, non-obstructive coronary artery disease. As lipoproteins in most TCM patients
were within the optimal range, we recommend an individual assessment of lipid profiles along with their coronary
heart disease risk factors for considering long term lipid-lowering therapy. A finding of hyperalphalipoproteinemia
or hypotriglyceridemia in 40% of TCM patients is novel but this association needs to be confirmed in future studies
with larger sample sizes. These findings may provide clues in understanding the pathogenesis of takotsubo
cardiomyopathy.
Background
Takotsubo cardiomyopathy (TCM) is gaining increasing
popularity due to its heightened awareness among wes-
tern nations [1]. Emotional or physical stress, leading to
catecholamine surge causing myocardial stunning is the
most widely accepted mechanism [2]. Presenting symp-
toms of TCM are similar to acute coronary syndrome
(ACS) with the vast majority complaining of chest pain,
associated with electrocardiographic changes, mild ele-
vation of cardiac biomarkers, “octopus pot/apical
ballooning” appearance on ventriculogram, and non-
obstructive coronary arteries. The reversal of cardiomyo-
pathy in a few days to a few weeks is a characteristic
feature [3].
Most patients with TCM have a favorable prognosis
and the treatment is geared towards managing systolic
heart failure by using aspirin,d i u r e t i c s ,b e t a - b l o c k e r s
and ACE inhibitors. Our electronic search in the MED-
LINE database (accessed via PUBMED) using a detailed
search strategy found only one retrospective study com-
paring medical therapy and outcomes in TCM patients
[4]. This study by Fazio et al in 2007 suggested there
was no benefit of long term therapy in TCM patients by
administering either aspirin,d i u r e t i c s ,b e t a - b l o c k e r s ,
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ever, this study did not analyze the role of lipid-lowering
therapy in TCM patients.
In the setting of ACS, early and aggressive statin ther-
apy is beneficial [5]. Since TCM patients have a presen-
tation similar to ACS, they are started on aggressive
statin therapy upon hospitalization. We presumed, since
the underlying pathology in TCM is not atherosclerotic
in nature, the lipid panels in TCM patients would be in
t h eo p t i m a lr a n g ea n dw o u l dd i f f e rf r o mt h o s ew i t h
atherosclerotic coronary heart disease.
Methods
We retrospectively evaluated patients diagnosed in our
hospital with TCM and myocardial infarction (MI)
between January 2005 and April 2010. In this five year
period, a total of fourteen patients were diagnosed with
TCM. Out of these fourteen patients, four were
excluded from the study because two patients were diag-
nosed based on echocardiographic findings without a
diagnostic coronary angiogram and two others did not
have an in-hospital lipoprotein level measurement. We
compared lipoprotein levels of the remaining ten TCM
patients with forty randomly selected MI patients (both
ST and non-ST elevation MI), who were matched by
age and gender.
Lipoprotein levels were retrospectively retrieved from
patient records. The coronary angiograms of all selected
subjects were reviewed independently by two cardiolo-
gists. TCM patients were confirmed to have non-
obstructive coronary arteries (< 50% diameter stenosis)
with typical apical and/or mid-ventricular wall motion
abnormalities. All patients in the TCM group had com-
plete recovery of cardiomyopathy, evidenced by clinical
improvement and assessment of left ventricular function
using transthoracic echocardiogram. The patients in the
MI group had angiographic evidence of severe obstruc-
tive coronary artery disease (> 50% diameter stenosis)
and underwent revascularization procedures.
Hypertension, diabetes, peripheral arterial disease, and
abdominal aortic aneurysm were defined by a history or
treatment of these conditions. Dyslipidemia was defined
by a history of abnormal cholesterol (total cholesterol >
200 mg/dL, HDL < 40 mg/dL, LDL > 130 mg/dL, or tri-
glycerides > 200 mg/dL) or currently taking any lipid-
lowering medications. Smoking history was considered
positive if they had ever smoked in their lives. Family
history of premature coronary artery disease (first-
degree relative < 55 years in men, < 65 years in women)
was obtained. Body mass index (BMI) was calculated
based on height and weight. The institutional review
board (IRB) of Staten Island University Hospital
approved the protocol.
Results
Clinical characteristics of TCM patients
In the TCM group, eighty percent of the population
were women and were all postmenopausal. The mean
age of patients was 62 years (range, 54 to 68 years) and
mean BMI was 23.9 kg/m2 (range, 19.1 kg/m2 to 31.1
kg/m2). The most common presenting complaint to the
hospital was chest pain (90%) and in a few patients was
associated with shortness of breath (20%), syncopal epi-
sode (10%) or palpitations (10%). Most patients had
either two or more coronary risk factors, but none had
a prior history of coronary artery disease or coronary
heart disease equivalents. All patients in the TCM group
were non-diabetics and their mean blood glucose level
at the time of admission (non-fasting) was 121.4 mg/dL.
The most common electrocardiographic findings at pre-
sentation were prolonged corrected QT intervals (60%)
and ST elevations (50%). The average peak troponin I
elevation was 3.2 ng per milliliter (normal value < 0.03
ng per milliliter) and the average peak creatine kinase
MB level was 21.09 ng per milliliter (normal value < 5.0
ng per milliliter). Severe left ventricular dysfunction was
present in all TCM patients with the mean ejection frac-
tion at presentation being 30%.
Clinical characteristics have been described in Table 1.
Lipoprotein Levels in TCM vs. MI patients
In the TCM group, the mean total cholesterol was 174.5
mg/dL (range 115-235 mg/dL), the mean HDL-C level
was 66.87 mg/dL (range 30-135 mg/dL), the mean LDL-
C level was 89.7 mg/dL (range 69-121 mg/dL), and
mean triglyceride level was 65.2 mg/dL (range 34-113
mg/dL). All TCM patients had an LDL-C < 130 mg/dL
and only one patient had an HDL-C < 40 mg/dL. Two
other patients had unusually high levels of HDL-C of 93
and 135 mg/dL, which are in the range of hyperalphali-
poproteinemia. Two other patients had mild hypotrigly-
ceridemia with triglyceride levels of 34 and 36 mg/dL.
In the MI group, the mean total cholesterol was 197.6
mg/dL (range 93-363 mg/dL), mean HDL-C was 36.5
mg/dL (range 18-61 mg/dL), mean LDL-C was 128.9
mg/dL (range 41-232 mg/dL) and mean triglyceride
level was 166.9 mg/dL (range 46-388 mg/dL).
Comparing serum lipoprotein levels of the TCM
group with the MI group, there was no significant dif-
ference in mean total cholesterol between the two
groups (174.5 mg/dL vs. 197.6 mg/dL, p = 0.12). How-
ever, in the TCM group, mean the HDL-C was signifi-
cantly higher (66.87 mg/dL vs. 36.5 mg/dL, p = 0.008),
the mean LDL-C was significantly lower (89.7 mg/dL vs.
128.9 mg/dL, p = 0.0002), and the mean triglyceride
level was significantly lower (65.2 mg/dL vs. 166.8 mg/
dL, p < 0.0001).
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The main results of our study are: (a) The TCM group
had significantly higher HDL-C (p = 0.008), lower LDL-
C (p = 0.0002) and lower triglycerides (p < 0.0001) com-
pared to age and sex-matched MI patients; and (b)
Hyperalphalipoproteinemia or mild hypotriglyceridemia
was noted in 40% of TCM patients.
The American Heart Association (AHA) and Adult
Treatment Panel (ATP Ш) guidelines recommend a tar-
get LDL-C of less than 130 mg/dL in patients with two
or more coronary risk factors and have no evidence of
coronary heart disease or coronary heart disease equiva-
lents [6]. In our study, most patients with TCM had two
or more coronary heart disease risk factors, but their
mean LDL-C was 89.7 mg/dL (range 69-121 mg/dL),
mean HDL-C was 66.87 mg/dL and mean triglycerides
was 65.2 mg/dL, which is considered optimal by AHA/
ATP Ш guidelines. In the MI group, the mean LDL-C
was 128.9 mg/dL and mean HDL-C was 36.5 mg/dL,
these findings of elevated of LDL-C and low HDL-C are
consistent with prior studies on myocardial infarction
and support the need for early and aggressive lipid-low-
ering therapy [7]. Multiple studies on TCM have estab-
lished a non-atherosclerotic, non-obstructive coronary
artery disease pattern and our study supports these find-
ings by demonstrating the existence of a healthy lipid
panel in this population.
Hypotriglyceridemia is a rare entity that can occur in
severe malnutrition and some autoimmune diseases. In
one research study, hypotriglyceridemia was shown to
be a precocious marker for autoimmunity [8]. Though
TCM-like autoimmune diseases is predominant in
female population, currently there is no evidence to sup-
port an autoimmune component in TCM pathogenesis.
None of our patients had a history or symptoms sugges-
tive of autoimmune diseases. Hyperalphalipoproteinemia
was noted in two other TCM patients, a term used
when HDL-C levels are more than 90 mg/dL. The
major function of HDL-C is reverse cholesterol
transport, during which, peripherally deposited choles-
terol is transferred to the liver. High HDL-C is protec-
tive [9] and is associated with low VLDL and low
triglycerides, as observed in our patients in TCM group.
Metabolic abnormality has been suggested to play a role
in TCM pathogenesis, whether these findings play a role
in the inverse metabolic-perfusion mismatch observed
in nuclear imaging studies needs further investigation
[10-12].
Our observational study, like most studies on TCM,
has a major limitation of small sample size due to the
rarity of the disease. Also, there is a controversy on
assessing serum lipid levels during hospitalization, due
to the wide range of variability noted with the in-hospi-
tal and 1-2 months post-discharge lipoprotein measure-
ment [13-15]. It is postulated that in acute coronary
syndrome, serum triglycerides act as acute phase reac-
tants and its variability with fasting states alters the
assessment of serum lipoprotein measurements [16].
However, recent trials with large sample sizes concluded
that mean serum LDL-C and other lipoproteins vary
minimally in the early days of hospitalization and are
reliable enough to start lipid-lowering therapy [17].
Conclusion
In conclusion, the lipid panels in TCM were signifi-
cantly healthier and different from the MI group and
add to the evidence that the pathogenesis of TCM is
not due to atherosclerotic blockage of epicardial coron-
ary arteries. Long term lipid lowering therapy in TCM
should be individualized based on the coronary risk fac-
tors and their serum lipoprotein levels. In this single
center experience, TCM patients had significantly higher
HDL-C levels, and lower LDL-C levels and triglyceride
levels in comparison to the MI group.
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Table 1 Clinical characteristics of Takotsubo cardiomyopathy patients
Patient No. AGE SEX RACE TC LDL HDL TRIG VLDL LVEF%
1 65 F C 221 76 135 50 9 30
2 65 F C 235 116 93 113 22 25
3 64 F C 170 73 66 36 6 35
4 61 F C 177 96 64.5 82 14 25
5 65 F AA 162 90 65 34 6 35
6 54 F C 156 73 61 71 12 20
7 60 M C 145 76 56 63 11 25
8 60 M C 190 121 53 81 14 30
9 68 F C 174 107 46 64 12 45
10 61 F C 115 69 30 58 11 30
C - CAUCASIAN, AA - AFRICAN AMERICAN, TC - TOTAL CHOLESTEROL, TRIG - TRIGLYCERIDES, LVEF%- LEFT VENTRICULAR EJECTION FRACTION AT PRESENTATION
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